PTAFR and pneumonia: The identified AP off-targets, TBXA2R and PTAFR, in black, are linked, either directly or indirectly, to a group of nodes, shown in blue, which likely contribute to the increased risk of developing pneumonia-related symptoms after activation of TBXA2Ror PTAFR.